Bristol Myers Squibb Partners with Veeva Systems to Transform Customer Engagement with Vault CRM

In a significant move that underscores the growing importance of technology in the healthcare sector, Veeva Systems Inc. (NYSE: VEEV) announced on September 22, 2025, that Bristol Myers Squibb (BMS) has officially committed to utilizing Veeva Vault CRM. This collaboration aims to enhance how healthcare practitioners engage with information about innovative medicines and streamline the process of patient care.

Greg Meyers, Executive Vice President and Chief Digital and Technology Officer at Bristol Myers Squibb, emphasized the pivotal role technology plays in reshaping customer engagement. "Technology is fundamentally reshaping the way we engage with our customers and the patients they serve," Meyers stated. By integrating Veeva Vault CRM, BMS seeks to revolutionize decision-making processes for healthcare practitioners amid an increasingly complex landscape of available medicines.

Meyers further noted the importance of artificial intelligence (AI) in this initiative. "By embedding AI into every step of the customer journey — from how practitioners receive valuable information about our portfolio to how they engage with our field force — Veeva is ideally positioned to support us in our mission to deliver life-changing medicines to patients worldwide," he remarked. This integration of AI aims to enhance the efficiency and effectiveness of healthcare engagement, ensuring practitioners have timely access to critical information.

Peter Gassner, CEO of Veeva Systems, expressed gratitude for the trust placed in the company by Bristol Myers Squibb. "We appreciate the trust and partnership and are committed to supporting Bristol Myers Squibb in their mission to provide medicines that transform the lives of patients with serious diseases," Gassner stated. He highlighted that with the introduction of Vault CRM, Veeva is delivering a next-generation customer relationship management platform, complete with embedded AI agents designed to facilitate improved engagement with healthcare practitioners.

Veeva Vault CRM is part of the broader Vault CRM Suite, which serves as a technological foundation for commercial execution in the life sciences industry. Among the exciting features set to debut in December 2025 are the first Veeva AI agents, including the Pre-call Agent, Content Agent, Free Text Agent, and Voice Agent. These innovations promise to enhance communication and operational efficiency, ultimately benefiting patient care.

The partnership between Bristol Myers Squibb and Veeva Systems marks a significant step forward in the integration of advanced technology within the healthcare industry. By leveraging Veeva Vault CRM and its AI capabilities, BMS aims to improve the way healthcare practitioners access and utilize critical information about innovative medicines. As the landscape of healthcare continues to evolve, this collaboration stands as a testament to the power of technology in transforming patient care and enhancing the overall healthcare experience.

Veeva Systems is a leader in delivering cloud-based solutions tailored for the life sciences industry. With a commitment to innovation, product excellence, and customer success, Veeva supports over 1,500 clients, including some of the largest biopharmaceutical companies and emerging biotech firms. As a Public Benefit Corporation, Veeva is dedicated to balancing the interests of all stakeholders, including customers, employees, shareholders, and the broader industry. For more information, visit veeva.com.